系列CT评估肺部病灶体积可预测侵袭性肺曲霉病的生存
本研究对一项侵袭性肺曲霉病治疗临床试验中的CT图像进行再评估,手动测量病灶总体积并与生物标志物比较。40例患者共190次CT和309个随访数据集显示,第7天病灶体积及第7至14天变化趋势是死亡的强预测因子,CT预测价值超过其他生物标志物。
要点
- 第7天病灶体积及第7至14天变化趋势是死亡的强预测因子。
- 第7至14天CT病灶体积任何增加均是致死结局(>50%)的敏感标志。
- CT预测价值超过半乳甘露聚糖、血细胞计数和病灶计数。
核心结论
- 第7至14天CT病灶体积任何增加是致死结局(>50%)的敏感标志,支持在初始检出IPA后第1周和第2周各复查一次CT;第14天应答后进一步CT随访的附加价值低。
研究设计与样本
- 对一项侵袭性肺曲霉病治疗临床试验的数字CT图像进行再评估,并与可获得的生物标志物比较;手动测量每个病灶后累加肺炎总体积,随后进行统计分析;共纳入40例患者的190次CT扫描和309个随访数据集,其中31例为中性粒细胞减少。
诊断标准与关键数值
- 基线半乳甘露聚糖预测死亡OR 4.06(95%CI 1.08-15.31),基线病灶体积预测死亡OR 3.14(95%CI 0.73-13.52);第7天病灶体积预测死亡OR 20.01(95%CI 1.42-282.00),第7至14天变化趋势预测死亡OR 15.97(95%CI 1.62-157.32);第7天病灶体积预测治疗被评为不成功OR 4.75(95%CI 0.94-24.05),第7至14天变化趋势预测治疗不成功OR 40.69(95%CI 2.55-649.03)。
临床应用与阅片要点
- CT评估对侵袭性肺曲霉病结局有良好预测价值,第7至14天任何进展构成高风险情景,支持初始检出后第1周和第2周各复查一次CT;第14天应答后进一步CT随访附加价值低。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Serial chest CT is the standard of care to establish treatment success in invasive pulmonary aspergillosis (IPA). Data are lacking how response should be defined.
METHODS: Digital CT images from a clinical trial on treatment of IPA were re-evaluated and compared with available biomarkers. Total volume of pneumonia was added up after manual measurement of each lesion, followed by statistical analysis.
RESULTS: One-hundred and ninety CT scans and 309 follow-up datasets from 40 patients were available for analysis. Thirty-one were neutropenic. Baseline galactomannan (OR 4.06, 95%CI: 1.08-15.31) and lesion volume (OR 3.14, 95%CI: 0.73-13.52) were predictive of death. Lesion volume at d7 and trend between d7 and d14 were strong predictors of death (OR 20.01, 95%CI: 1.42-282.00 and OR 15.97, 95%CI: 1.62-157.32) and treatment being rated as unsuccessful (OR 4.75, 95%CI: 0.94-24.05 and OR 40.69, 95%CI: 2.55-649.03), which was confirmed by a Cox proportional hazards model using time-dependent covariates.
CONCLUSION: Any increase in CT lesion volume between day 7 and day 14 was a sensitive marker of a lethal outcome (>50%), supporting a CT rescan each one and 2 weeks after initial detection of IPA. The predictive value exceeded all other biomarkers. Further CT follow-up after response at day 14 was of low additional value.
KEY POINTS: • CT evaluation offers good prediction of outcome for invasive pulmonary aspergillosis. • Predictive capability exceeds galactomannan, blood counts, and lesion count. • Any progression between day 7 and day 14 constitutes a high-risk scenario.
引用
- Vehreschild JJ, Heussel CP, Groll AH, et al. Serial assessment of pulmonary lesion volume by computed tomography allows survival prediction in invasive pulmonary aspergillosis. Eur Radiol. 2017. PMID: 28083695. doi:10.1007/s00330-016-4717-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。